Episodios

  • USPSTF 2024 Breast Cancer Screening Guideline Update!

    USPSTF 2024 Breast Cancer Screening Guideline Update!
    May 7 2024

    We're back!
    Más Menos
    16 m
  • A New Pandemic? PICKLEBALL INJURIES ON THE RISE!

    A New Pandemic? PICKLEBALL INJURIES ON THE RISE!
    Jul 7 2023

    Fun, quick episode this week.

    https://pubmed.ncbi.nlm.nih.gov/33934725/

    Non-fatal senior pickleball and tennis-related injuries treated in United States emergency departments, 2010-2019

    Harold Weiss 1, Jacob Dougherty 2, Charles DiMaggio 3
    Más Menos
    5 m
  • First Unprovoked VTE, Cause for Lifelong Blood Thinners?

    First Unprovoked VTE, Cause for Lifelong Blood Thinners?
    Jul 4 2023

    Today's episode is a very complicated topic without clear cut benefits. Expert opinions and modeling data to address a dangerous and serious topic. Let's look at 2 sources: a new study from the Annals of Internal Medicine and an expert opinion from Uptodate.

    https://www.uptodate.com/contents/selecting-adult-patients-with-lower-extremity-deep-venous-thrombosis-and-pulmonary-embolism-for-indefinite-anticoagulation?search=unprovoked%20dvt§ionRank=1&usage_type=default&anchor=H648618&source=machineLearning&selectedTitle=1~150&display_rank=1#H648618

    vs.

    https://pubmed.ncbi.nlm.nih.gov/37364263/

    Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study

    Faizan Khan 1, Doug Coyle 2, Kednapa Thavorn 3, Sasha van Katwyk 4, Tobias Tritschler 5, Brian Hutton 6, Grégoire Le Gal 7, Marc A Rodger 8, Dean A Fergusson 9
    Más Menos
    16 m
  • Intermittent Fasting vs. Caloric Restriction, Head to Head!

    Intermittent Fasting vs. Caloric Restriction, Head to Head!
    Jun 28 2023

    Time restricted eating vs. caloric restriction. Is there a winner in this 1:1:1 12-month trial from Chicago?

    https://pubmed.ncbi.nlm.nih.gov/37364268/

    Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial Shuhao Lin 1, Sofia Cienfuegos 1, Mark Ezpeleta 1, Kelsey Gabel 1, Vasiliki Pavlou 1, Andrea Mulas 1, Kaitie Chakos 1, Mara McStay 1, Jackie Wu 1, Lisa Tussing-Humphreys 2, Shaina J Alexandria 3, Julienne Sanchez 4, Terry Unterman 5, Krista A Varady 1
    Más Menos
    16 m
  • New RSV Vaccine Studies!

    New RSV Vaccine Studies!
    May 24 2023

    Talking about 2 studies released last month:

    1. Giving it to 3rd trimester moms and seeing what happens in newborns:

    https://pubmed.ncbi.nlm.nih.gov/37018474/

    2. Giving it to 60+ yo adults and seeing what happens:

    https://pubmed.ncbi.nlm.nih.gov/37018468/

    What happens when I review these? Listen to find out!

    Helpful table (Not sure if this will reproduce well or not):

    NNT Vaccine Efficacy Severe LRI first 90 d 142 81% In 6 mo 75 69% ADULTS 1428 85% non-severe LRI first 90 d 111 57 6mo 55 51% ADULTS 769 66% Any URI ADULTS 500 62%

    Más Menos
    23 m
  • Personalization - A New Treatment Algorithm for Blood Pressure Management

    Personalization - A New Treatment Algorithm for Blood Pressure Management
    Apr 25 2023

    Hey everyone, on today's episode we are talking about a recent JAMA article on Heterogeneity in Blood Pressure Response to various blood pressure medicines and the idea of individualizing antihypertensive algorithms.

    https://jamanetwork.com/journals/jama/article-abstract/2803518
    Más Menos
    14 m
  • Treating Resistant Depression in Elders - Add or Switch Meds?

    Treating Resistant Depression in Elders - Add or Switch Meds?
    Mar 21 2023

    Today's episode we look at a study of 60+ year olds who have poorly controlled depression. Is it better to add on medications? Switch medications? Does it matter?

    Study link:

    https://pubmed.ncbi.nlm.nih.gov/36867173/
    Más Menos
    17 m
  • New(ish) Drug for MACE Prevention

    New(ish) Drug for MACE Prevention
    Mar 5 2023

    Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.
    Más Menos
    16 m
adbl_web_global_use_to_activate_webcro805_stickypopup